Difficulty: Medium
Average Score: 78%
Practice
A patient is in the emergency department with a new onset of rapid-rate atrial fibrillation, and the nurse is preparing a continuous infusion. Which drug is most appropriate for this dysrhythmia?
Correct answer
A
Rationale
In the scenario of a patient presenting with rapid-rate atrial fibrillation in the emergency department, the most appropriate drug for this dysrhythmia is diltiazem (Cardizem). Diltiazem is a calcium channel blocker that helps to slow down the heart rate by blocking calcium channels in the cardiac conduction system. This effect is particularly beneficial in atrial fibrillation where the heart is beating rapidly and irregularly.
Option B, atenolol (Tenormin), is a beta-blocker which is not the first-line treatment for rapid atrial fibrillation. Beta-blockers are more commonly used for rate control in stable atrial fibrillation or in cases where there is concomitant hypertension or heart failure.
Option C, lidocaine, is a local anesthetic and antiarrhythmic drug that is not typically used for atrial fibrillation. Lidocaine is more commonly used for ventricular arrhythmias.
Option D, adenosine (Adenocard), is a medication used for the treatment of supraventricular tachycardias, such as supraventricular tachycardia (SVT) or atrioventricular nodal reentrant tachycardia (AVNRT). It is not indicated for atrial fibrillation.
In an educational context, understanding the mechanism of action of different antiarrhythmic medications is crucial for selecting the most appropriate drug for specific cardiac arrhythmias. Diltiazem's ability to slow down the heart rate by blocking calcium channels makes it a suitable choice for patients with rapid atrial fibrillation. This knowledge is essential for healthcare providers managing patients with cardiovascular conditions in various clinical settings.
Option B, atenolol (Tenormin), is a beta-blocker which is not the first-line treatment for rapid atrial fibrillation. Beta-blockers are more commonly used for rate control in stable atrial fibrillation or in cases where there is concomitant hypertension or heart failure.
Option C, lidocaine, is a local anesthetic and antiarrhythmic drug that is not typically used for atrial fibrillation. Lidocaine is more commonly used for ventricular arrhythmias.
Option D, adenosine (Adenocard), is a medication used for the treatment of supraventricular tachycardias, such as supraventricular tachycardia (SVT) or atrioventricular nodal reentrant tachycardia (AVNRT). It is not indicated for atrial fibrillation.
In an educational context, understanding the mechanism of action of different antiarrhythmic medications is crucial for selecting the most appropriate drug for specific cardiac arrhythmias. Diltiazem's ability to slow down the heart rate by blocking calcium channels makes it a suitable choice for patients with rapid atrial fibrillation. This knowledge is essential for healthcare providers managing patients with cardiovascular conditions in various clinical settings.